US-Japan Health Sciences Dialogue _ by Japan America Society of Greater Philadelphia

The US-Japan Health Sciences Dialogue is a global event for collaboration attended by Western, Japanese, and Asian biopharmaceutical executives, dealmakers, investors, professional advisors, and policy KOLs who wish to share their insights on best practices and growth opportunities. Informative panel discussions, company presentations, and partnering are all designed to facilitate collaboration and provide attendees with an enhanced ROI.

Since its inception, the US-Japan Health Sciences Dialogue, going into its 13th year, has been focused on supporting dialogue, understanding and collaboration between biopharmaceutical companies in two of the most important global markets in the East and West. The meeting has evolved from focusing on a specific theme to an event focused on trans-Pacific deals, alliances, and investments. The goal of the Health Sciences Dialogue is to facilitate global collaboration.

The Health Sciences Dialogue features plenary sessions, workshops, company presentations, partnering meetings, and multiple networking opportunities.

Inaugurated by the Japan America Society of Greater Philadelphia in March 2000, the US-Japan Health Sciences Dialogue is co-produced by the Japan America Society of Greater Philadelphia and Demy-Colton Life Science Advisors. The Japan America Society of Greater Philadelphia represents a community that includes many Japanese based biopharmaceutical companies. Demy-Colton Life Science Advisors is an organization dedicated to supporting the growth of the life sciences industry.

Participate in the Discussion

• Global Healthcare Policy and Potential Non-Dilutive Funding Options for Drug Developers
• Health Sciences Dialogue Picks the Most Interesting East-West Deals of 2013
• The Evolution of Japanese Pharma Companies In a Global Environment
• Comparative Regulatory Machinery: A Look at the US, Japan and Europe and Making It Work
• Investors Speak: What Opportunities Are They Looking for and What Do They Want To See?

How You Can Participate

• Nominate deals, alliances and/or investments to be discussed
• Present your company
• Participate as a panelist
• Become a sponsor
• Register to attend

Who Should Attend?

Senior biopharmaceutical executives, dealmakers, investors, professional advisors, and policy KOLs from North America, Europe, Japan, and Asia.